Cite Filings / FENC / 0001493152-26-019342

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

FENNEC PHARMACEUTICALS INC. Filed 2026-04-28 Acc 0001493152-26-019342

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-05-01 4 Chief Commercial Officer acquired 168 shares (option exercise)
2026-05-01 144 Sale of Securities
2026-05-01 4 Director sold 10,781 shares at $6.47 ($69,753)
2026-04-28 SCHEDULE 13G Statement of Beneficial Ownership
2026-04-28 8-K Executive or director change
2026-04-28 DEF 14A Proxy Statement
2025-11-13 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…